The Senate Judiciary Committee held a hearing to examine competition in the prescription drug market, focusing on patent abuses and promoting competition to lower drug prices. Various experts and lawmakers highlighted the need to address pharmaceutical companies' practices of artificially raising prices through patent system abuse. The hearing emphasized the importance of affordable and accessible medications for patients.
Corporate price gouging and shrinkflation are hurting our seniors on fixed incomes, college students struggling to get by and working families across the country. I'm holding a @SenateBanking hearing on how to fight back to lower costs. Tune in: https://t.co/5WXN8WAexT
The FDA plays a vital role in developing new medications, but this is only beneficial if patients can access & afford them. Today in @EnergyCommerce, I urged my colleagues to support my legislation to encourage competition & ensure approvals are not delayed due to patent gaming. https://t.co/3ULmDG11A9
Life is too expensive for working Minnesota families right now – we must do everything we can to make life more affordable. That’s why I’m working to create a federal task force that will crack down on corporate price gouging and lower costs at the grocery store. https://t.co/IVK1ipitjU
Happening now ➡️ Health Subcommittee hearing titled "Check Up: Examining FDA Regulation of Drugs, Biologics, and Devices." 🥼 https://t.co/8TMDWKBril
WATCH LIVE: Health hearing on @US_FDA's regulation of prescription drugs, biologics, and medical devices to ensure they are safe and effective for patients ⬇️
Lawmakers across the political divide accused the #pharma industry of abusing the patent system to keep the prices of their products as high as possible at a fiery @JudiciaryDems committee hearing. https://t.co/d7voMr0Y92
Senate Judiciary Committee members expressed strong bipartisan support for patent reform to prevent pharmaceutical companies from artificially raising prices. https://t.co/CbnlgMWfsZ
The drug industry’s top lobbying group faced fierce questioning at a Senate Judiciary Committee hearing that explored whether abuse of the patent system is responsible for keeping prescription drug prices sky-high in the U.S. https://t.co/QtXWC7EfI4
More corporations should answer @POTUS’s call to lower prices for consumers, instead of price gouging and raking in record profits. I’m leading a @SenateBanking hearing tomorrow on how to lower food prices by fighting corporate consolidation. https://t.co/xyTD6JVbrk
I’m taking on Big Pharma to lower the cost of prescription drugs for everyone who depends on them. We’ve made great progress – including capping insulin at $35/month for Medicare recipients – but there’s always more to be done.
Hardworking Pennsylvanians shouldn’t be paying more for their groceries just so CEOs can line their pockets with record profits. Watch my interview with Blue Ridge Cable where I outline the steps I’m taking to curb corporate greed & price gouging to lower food costs across PA. https://t.co/OYOyO5eL7n
Thank you @ChuckGrassley for asking what will help “find the next miracle drug without breaking patients’ pocketbooks?” @AdamMossoff: “reliable and effective patent rights.” Reduced innovation will only lead to sicker patients and higher costs. @JudiciaryDems @SenJudiciaryGOP
.@AdamMossoff’s expert testimony from today’s @JudiciaryDems @SenJudiciaryGOP hearing highlights the importance of patents: “Today, the US is a global leader in healthcare innovation.” Stripping #IP rights by warping Bayh-Dole will threaten this success.
Tune in as I speak during the @JudiciaryDems hearing about how Big Pharma is rigging the patent system to charge sky-high prices on prescription drugs. https://t.co/ngRVMB9bJ7
Happening now: My @HudsonInstitute colleague @AdamMossoff testifies before the full Senate Judiciary Committee at its hearing on "Ensuring Affordable & Accessible Medications: Examining Competition in the Prescription Drug Market." WATCH: https://t.co/kU69ru3stP https://t.co/XB4o0IOfeT
The Inflation Reduction Act and Medicare negotiations have helped lower costs of prescription drugs. We need to go further. We’re holding a hearing to examine patent abuses and how to promote competition in the prescription drug market. Watch. https://t.co/ukAU8q0oxv
Patients need to access and afford their medications, yet Americans pay the highest prices in the world for drugs. Let’s build on the progress of the Inflation Reduction Act and Medicare negotiations – and further promote competition. Watch. https://t.co/woiFhp001V
WATCH | Today at 10AM: Prof. Arti Rai (@rai_arti), a patent law and policy expert, is speaking at the Senate Committee on the Judiciary’s hearing on “Ensuring Affordable & Accessible Medications: Examining Competition in the Prescription Drug Market.” https://t.co/EdtN5fJumZ
Senate Judiciary hearing today to examine competition in the prescription drug market